Login | Register / Chinese

Companies

Performance Review on China Listed Companies during the First Three Quarters
Source:China Crop Protection Industry Association  author: Cong Lv
  date: 2014-12-26  
view:

Sales Performance of China Listed Companies during the First Three Quarters (100 Million Yuan)

Company Name

Operating income

Year-on-year Basis(%)

Net Profit

Year-on-year Basis(%)

Zhejiang Wynca Chemical Industrial Group

58.98

+13.81

0.94

-73.89

Huapont Nutrichem

37.74

+17.89

3.69

+42.10

Jiangsu Yangnong Chemical Group

20.89

-5.08

3.17

+19.14

Nanjing RedSun

49.77

+1.60

3.98

+50.82

Sanonda

25.67

+13.77

4.29

+123.48

Lianhe Tech

29.02

+20.01

3.68

+24.42

Nantong Jiangshan Agrochemical & Chemical

23.20

-4.73

1.89

-19.44

Huifeng Joint-Stock

17.48

+14.08

1.56

+43.10

Noposion

19.10

+25.57

1.78

+4.69

Jiangsu Changqing Agrochemical

13.23

+12.71

1.77

+20.28

Lier Chemical

10.19

-6.07

0.88

-10.18

Jiangsu Lanfeng Bio-chemical

9.56

-9.08

-0.14

-150.99

Hunan Haili Group

8.02

-6.77

0.039

-49.31

Huaxing Chemical Industry

42.55

+60.21

0.77

+154.96

Zhejiang Shenghua Biok Biology

10.36

-12.70

0.97

+195.36

Hebei Veyong Bio-Chemical

35.34

+3.14

5.40

-6.07

Note: The operating income is the company’s entire business income. It includes business revenues from other sectors other than pesticides for some companies.

 

 

Market competition intensifies and the benefits of flagship products meet setback

 

 The net profits which belonged to the shareholders of Jiangsu Lanfeng Bio-chemical Co., Ltd. as a listed company in 2013 totaled 21.1017 million yuan. The market demand for Lanfeng Bio-chemical’s main profitable product hexazinone falters in 2014, so is the gross profit for Lanfeng Bio-chemical. Furthermore, due to the lack of raw material for some key products, the company’s productivity wasn’t fully released, so the expected profits has not been reached. It is estimated that the net profits which belong to the shareholders of Jiangsu Lanfeng Bio-chemical Co., Ltd. as a listed company in 2014 range between minus 10 million and 0 yuan.

 

The net profits which belonged to the shareholders of Lier Chemical as a listed company in 2013 totaled 104 million yuan. Under the influence of the overall international pesticide market of increasing competition, gross margin for the company’s old products such as picloram declined in 2014. In the meantime, due to the relocation project for technological innovations, the business performance of Jiangsu Kuaida Agrochemical Co., Ltd., a subsidiary of Lier Chemical, slowed down, which also contributed to the decline of the operating income of Lier Chemical. It is expected that the net profits which belong to the shareholders of Lier Chemical as a listed company in 2014 range between 83.2709 million and 114 million yuan, with a variation of -20.00% to 10.00%.

 

The net profit for the owners of the parent company of Wynca Chemical Industrial Group in the whole year of 2013 reached 435 million yuan. Glyphosate is Wynca Chemical Industrial Group’s flagship product, the price of which in 2014 has been declining during the reporting period. Meanwhile, the slack organosilicone industry has also brought down the products’ profitability level. The realized net profit which belonged to the owners of the parent company totaled 94.4026 million yuan during the first three quarters. It is expected that the realized net profit which belongs to the owners of the parent company will fall by over 50% compared with the same period of last year.

 

Expand the market with developments and innovations

 

The net profits which belonged to the shareholders of Huifeng Joint-Stock as a listed company in 2013 totaled 163 million yuan. During the first three quarters, Huifeng Joint-Stock has enhanced its efforts in expanding the market and controlling the cost. In the same time, the company has also been increasing the proportion of high-tech sales. It is expected that the net profits which belong to the shareholders of Huifeng Joint-Stock as a listed company in 2014 range between 212 million and 245 million yuan, with a variation of 30.00% to 50.00%.

 

The net profits which belonged to the shareholders of Lianhe Tech as a listed company in 2013 totaled 450 million yuan. Faced with the complicated domestic and international situation in 2014, Lianhe Tech constantly keeps strengthening the efforts in expanding the market. The sales of the company’s main products keeps growing, which maintains the sound development momentum for the company. Lianhe Tech also keeps enhancing innovations in R&D and technology improvements, promoting the managerial level of each link of the supply chain and making efforts to reduce relevant costs. It is expected that the net profits which belong to the shareholders of Lianhe Tech as a listed company in 2014 range between 539 million and 629 million yuan, with a variation of 20.00% to 40.00%.

 

The business performance of Sanonda has seen substantial growth during the reporting period, which mainly benefits from the company’s enhanced efforts to control the cost. The financial cost has dropped sharply on a year-on-year basis, and the scale benefits of the products have been improved. The company has also been constantly increasing its efforts in expanding the market. The sales of parts of the key products have increased and the selling prices of the products have risen remarkably. 

 

The net profits which belonged to the shareholders of Noposion as a listed company in 2013 totaled 180 million yuan. During the first three quarters, the company has further deepened its comprehensive agricultural services based on plant protection technologies, and the marketing efficiency maintains a stable growth. However, influenced by the litigation brought by Jiangsu Changlong Agrochemical, it is expected that the net profits which belong to the shareholders of Noposion as a listed company in 2014 range between 180 million and 216 million yuan, with a variation of 0.00% to 20.00%.

 

Expand the scale and improve the business performance 

 

The net profits which belonged to the shareholders of Huapont Nutrichem as a listed company in 2013 totaled 302 million yuan. Huapont Nutrichem s consolidated statements for 2014 include those of the newly merged companies Shandong Fuer Co., Ltd. and Shandong Kaisheng New Materials Co., Ltd. It is expected that the net profits which belong to the shareholders of Huapont Nutrichem as a listed company in 2014 range between 393 million and 484 million yuan, with a variation of 30.00% to 60.00% on a year-on-year basis.

 

The net profits which belonged to the shareholders of Jiangsu Changqing Agrochemical as a listed company in 2013 totaled 193 million yuan. With the completion and operation of the TC production base in Nantong in 2014, the business performance of the company is accordingly improved. It is expected that the net profits which belong to the shareholders of Jiangsu Changqing Agrochemical as a listed company in 2014 range between 212 million and 270 million yuan, with a variation of 10.00% to 40.00%.

 

Boost profits through multiple channels 

 

The net profits which belonged to the shareholders of Huaxing Chemical Industry as a listed company in 2013 totaled 44.0348 million yuan. The agricultural material business of Anhui Linearfull, a wholly-owned subsidiary of Huaxing Chemical Industry has grown substantially during 2014, which therefore has contributed a lot to the profits of Huaxing Chemical Industry. It is expected that the net profits which belong to the shareholders of Huaxing Chemical Industry as a listed company in 2014 range between 78 million and 98 million yuan, with a variation of 77.13% to 122.55% on a year-on-year basis.

 

The operating income of Veyong Bio-Chemical during the first three quarters in 2014 increased by 724.88% compared with the same period of last year. The main contributing factor for the company’s income growth lies in the assets disposal and amortization of deferred income during the reporting period.

 

The net profits which belonged to the shareholders of Zhejiang Shenghua Biok Biology as a listed company in 2013 totaled 27.7258 million yuan. Caitong Fund Management Co, Ltd., a joint-stock company of Shenghua Biok Biology, has actively adjusted the product design direction and expanded the special-account business while developing traditional public fund. Of a defined development course characteristic of future goods and stable-growth business, it is expected that the net profit of Caitong Fund Management will increase. Meanwhile, the interests of entrusted loans during current period and private placement bonds will greatly promote the company’s earnings. Furthermore, under the influence of the market, the sales revenue and gross margin of some of Shenghua Biok Biology’s veterinary medicine products will rise compared to the same period of last year. It is expected that the net profits which belong to the shareholders of Zhejiang Shenghua Biok Biology as a listed company in 2014 will increase by over 180% on a year-on-year basis.

Highlights